Shopping Cart

Remove All

Your shopping cart is currently empty

Peptide T acetate(106362-32-7 free base)

Select Batch

Purity:99.47%

Resource Download

COA MS HPLC

Peptide T acetate(106362-32-7 free base)

Catalog No. TP1785L

Peptide T acetate is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability
1 mg	$97	In Stock
5 mg	$273	In Stock
10 mg	$459	In Stock
25 mg	$755	In Stock
50 mg	$1,060	In Stock
100 mg	$1,430	In Stock
500 mg	$2,860	In Stock

Bulk & Custom

Add to Cart

Questions

Related Compound Libraries of "Peptide T acetate(106362-32-7 free base)"

Product Introduction

Bioactivity

Description	Peptide T acetate is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action
In vitro	Peptide T acts to block viral entry as it inhibits in the MAGI cell assay and blocks infection in the luciferase reporter assay using HIV virions pseudotyped with ADA envelope. Peptide T selectively inhibits HIV replication using chemokine receptor CCR5 compared to CXC4[2]. Peptide T at 10-8 M induces IL-10 production by the human Th2 cell line and PBMC. Also peptide T at 10-9 M concentration significantly inhibits IFN-g production by PBMC[3].
In vivo	Peptide T is administered subcutaneously at different doses and phases of the experimental autoimmune encephalomyelitis (EAE) disease, but Peptide T neither prevents nor ameliorates EAE[4].

Chemical Properties

Molecular Weight	917.91
Formula	C37H59N9O18
Cas No.

Storage & Solubility Information

Storage

keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

H2O: 5 mM

DMSO: Insoluble

Solution Preparation Table

H2O

	1mg	5mg	10mg	50mg
5 mM	0.2179 mL	1.0894 mL	2.1789 mL	10.8943 mL
10 mM	0.1089 mL	0.5447 mL	1.0894 mL	5.4472 mL
20 mM	0.0545 mL	0.2724 mL	0.5447 mL	2.7236 mL
50 mM	0.0218 mL	0.1089 mL	0.2179 mL	1.0894 mL
100 mM	0.0109 mL	0.0545 mL	0.1089 mL	0.5447 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc